NCT07882719

Brief Summary

\### Study Summary - AcuteBike-ICU Bed-cycling is commonly used as part of early rehabilitation in critically ill patients in the intensive care unit (ICU). However, the extent to which usual care bed-cycling activates the quadriceps muscles remains unclear, as does whether individualized exercise protocols can increase muscle stimulation. The AcuteBike-ICU study is an experimental study aiming to compare the acute physiological responses to three bed-cycling protocols in critically ill patients: usual care constant work-rate cycling (u-CWR), individualized constant work-rate cycling (i-CWR), and individualized interval training (i-IT). A total of 29 critically ill patients admitted to medical or surgical ICUs will be included. Participants will undergo an incremental loading test to determine their individual exercise capacity, followed by the different cycling protocols. The individualized continuous protocol involves cycling against a moderate resistance, whereas interval training alternates short periods of high-intensity cycling with passive cycling. The primary outcome is quadriceps muscle activation, assessed using surface electromyography (sEMG) across four quadriceps muscle regions. Secondary outcomes include muscle fatigue, activation heterogeneity, muscle oxygenation and metabolism assessed using near-infrared spectroscopy (NIRS), as well as safety, feasibility, and patient-reported symptoms. Retrospective data from routine bed-cycling sessions will also be analyzed to characterize current clinical practice. Each participant will complete the study within a maximum of five days. By identifying which cycling protocol elicits the greatest quadriceps muscle stimulation, this study aims to support the development of more individualized and potentially more effective early rehabilitation strategies for critically ill patients.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at below P25 for not_applicable

Timeline
6mo left

Started Nov 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 13, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 20, 2026

Completed
12 days until next milestone

Study Start

First participant enrolled

November 1, 2026

Expected
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2027

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2027

Last Updated

October 20, 2026

Status Verified

October 1, 2026

Enrollment Period

6 months

First QC Date

October 13, 2026

Last Update Submit

October 13, 2026

Conditions

Keywords

critical illnessearly mobilisationrehabilitationcycling

Outcome Measures

Primary Outcomes (1)

  • Average Quadriceps Muscle Activation During Bed-Cycling

    Average quadriceps muscle activation will be assessed using surface electromyography (sEMG) during the cycling protocols (u-CWR, i-CWR and i-IT). Activation will be expressed as normalized root mean square (RMS) amplitude relative to maximal voluntary contraction (%max), averaged across four quadriceps regions: vastus lateralis, vastus medialis, upper rectus femoris, and lower rectus femoris.

    During each bed-cycling session (Days 1-3; within a maximum of 5 days).

Secondary Outcomes (25)

  • Quadriceps muscle fatigue (Median Frequency)

    During the incremental loading test and each cycling session (Days 0-3; within 5 days).

  • Quadriceps muscle fatigue (Frequency ratio)

    During the incremental loading test and each cycling session (Days 0-3; within 5 days).

  • Spatial heterogeneity of quadriceps muscle activation

    During the incremental loading test and each cycling session (Days 0-3; within 5 days).

  • Quadriceps muscle oxygenation

    At rest, during and immediately after the incremental loading test and each cycling session (Days 0-3; within 5 days).

  • Quadriceps muscle hemoglobine and Myoglobine Responses (oxygenated)

    At rest, during and immediately after the incremental loading test and each cycling session (Days 0-3; within 5 days).

  • +20 more secondary outcomes

Other Outcomes (6)

  • Cycling Exercise Performance: resistance level

    During the incremental loading test and cycling sessions (Days 0-3; within 5 days).

  • Cycling Exercise Performance: cycling distance

    During the incremental loading test and cycling sessions (Days 0-3; within 5 days).

  • Cycling Exercise Performance: cadence

    During the incremental loading test and cycling sessions (Days 0-3; within 5 days).

  • +3 more other outcomes

Study Arms (2)

i-CWR / i-IT

EXPERIMENTAL

Individualized continuous work-rate cycling (i-CWR) will be provided on day 2, followed by the individualized interval training (i-IT) on day 3. Both individualized cycling modalities will be prescribed based on the results of the incremental loading test performed on day 1

Other: usual care constant work rate bedcyclingOther: Individualized constant work rate bedcyclingOther: Individualized interval bedcycling

i-IT / i-CWR

EXPERIMENTAL

Individualized interval training (i-IT) will be provided on day 2, followed by the individualized continuous work-rate cycling (i-CWR) on day 3. Both individualized cycling modalities will be prescribed based on the results of the incremental loading test performed on day 1

Other: usual care constant work rate bedcyclingOther: Individualized constant work rate bedcyclingOther: Individualized interval bedcycling

Interventions

Patients will perform interval cycling with alternating 30-second periods of active cycling at 100% of the maximal tolerated intensity level and 30-second periods of motor-assisted passive cycling without resistance. Patients will remain in the same body position as during the other cycling protocols and the cycling duration of the 2 individualized cycling protocols (i-CWR and i-IT) will be matched with a maximal duration of 20 minutes.

i-CWR / i-ITi-IT / i-CWR

Participants will perform a usual care cycling session using the bed cycle according to routine clinical practice. The training intensity will be determined by the treating physiotherapist, without knowledge of the maximal exercise capacity. The cycling session will last for a maximum of 20 minutes.

i-CWR / i-ITi-IT / i-CWR

patients will perform continuous active cycling at 50% of maximal exercise capacity. Patients will remain in the same body position as during the other cycling protocols and the cycling duration of the 2 individualized cycling protocols (i-CWR and i-IT) will be matched with a maximal duration of 20 minutes.

i-CWR / i-ITi-IT / i-CWR

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Voluntary written informed consent of the participant has been obtained prior to the initiation of any study-related measurements
  • Adults (≥18 years)
  • Mechanically ventilated for ≥ 48 hours consecutively
  • Fully cooperative, as assessed daily during routine clinical care by ICU physiotherapists using five standardized commands ("open/close your eyes", "look at me", "open your mouth and stick out your tongue", "nod your head", and "raise your eyebrows when I have counted to 5").
  • Able to perform active cycling for \>10 consecutive minutes
  • Expected to remain in the ICU for more than an additional 4 days starting from study enrolment.

You may not qualify if:

  • Evidence of acute coronary ischemia
  • Heart rate \<40 or \>120 beats per minute
  • Mean arterial pressure \<60 or \>110 mmHg
  • Noradrenaline or comparable inotropic or vasopressor support (norepinephrine \>0.2ug/kg/min, dobutamine \>5ug/kg/min, corotrope \>0.2 ug/kg/min) B. Respiratory instability
  • Fraction of inspired oxygen ≥ 60%
  • PaO₂/FiO₂ ratio \< 200
  • Positive end-expiratory pressure \> 10 cmH2O
  • Respiratory rate \> 30 breaths·min-¹ C. Surgery within the past 24h D. Body temperature \> 40 oC CONDITIONS IMPAIRING CYCLING MOVEMENT
  • Trauma or surgery to lower limb, pelvis lumbar spine
  • Extreme obesity (body mass index \>35 kg/m2)
  • Extensive abdominal wounds or pressure ulcers
  • Continuous renal replacement therapy by CVVH-femoral catheter PALIATIVE CARE

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor Faculty of Movement and Rehabilitation Sciences

Study Record Dates

First Submitted

October 13, 2026

First Posted

October 20, 2026

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

May 1, 2027

Last Updated

October 20, 2026

Record last verified: 2026-10

Data Sharing

IPD Sharing
Will not share